Pier Luigi Tazzari
Overview
Explore the profile of Pier Luigi Tazzari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1529
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Storci G, De Felice F, Ricci F, Santi S, Messelodi D, Bertuccio S, et al.
J Clin Invest
. 2024 Jun;
134(14).
PMID: 38833312
BACKGROUNDPredicting immune effector cell-associated neurotoxicity syndrome (ICANS) in patients infused with CAR T cells is still a conundrum. This complication, thought to be consequent to CAR T cell activation, arises...
2.
Varrone E, Carnicelli D, He X, Grasse M, Stampfer K, Huber S, et al.
Toxins (Basel)
. 2023 Dec;
15(12).
PMID: 38133194
Typical hemolytic uremic syndrome (HUS) is mainly caused by Shiga toxin-producing (STEC) releasing Shiga toxin 2 (Stx2). Two different structures of this AB5 toxin have been described: uncleaved, with intact...
3.
Storci G, Barbato F, Ricci F, Tazzari P, De Matteis S, Tomassini E, et al.
Front Immunol
. 2023 Jan;
13:1058739.
PMID: 36713433
Graft versus host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (HSCT). Rabbit anti-T lymphocyte globulin (ATLG) in addition to calcineurin inhibitors and antimetabolites is a...
4.
Palandri F, Di Pietro C, Ricci F, Tazzari P, Randi V, Bartoletti D, et al.
Res Pract Thromb Haemost
. 2021 Dec;
5(8):e12606.
PMID: 34938937
Recently, treatment of immune-mediated thrombotic thrombocytopenic purpura (ITTP) has changed with the advent of caplacizumab in clinical practice. The International Working Group (IWG) has recently integrated the ADAMTS-13 activity/autoantibody monitoring...
5.
Barone M, Barone M, Ricci F, Auteri G, Corradi G, Fabbri F, et al.
Front Oncol
. 2021 Dec;
11:715217.
PMID: 34900671
Polycythemia Vera (PV) is a myeloproliferative neoplasm with increased risk of thrombosis and progression to myelofibrosis. Chronic inflammation is commonly observed in myeloproliferative neoplasms including PV. The inflammatory network includes...
6.
Barone M, Barone M, Ricci F, Auteri G, Fabbri F, Bandini E, et al.
Cancers (Basel)
. 2021 Oct;
13(19).
PMID: 34638452
Polycythemia vera is a myeloproliferative neoplasm with increased risk of thrombosis and progression to myelofibrosis. However, no disease-specific risk factors have been identified so far. Circulating extracellular vesicles (EVs) are...
7.
Barone M, Catani L, Ricci F, Romano M, Forte D, Auteri G, et al.
Oncoimmunology
. 2020 Sep;
9(1):1782575.
PMID: 32923146
Myelofibrosis (MF) is characterized by chronic inflammation and hyper-activation of the JAK-STAT pathway. Infections are one of the main causes of morbidity/mortality. Therapy with Ruxolitinib (RUX), a JAK1/2 inhibitor, may...
8.
Brigotti M, He X, Carnicelli D, Arfilli V, Porcellini E, Galassi E, et al.
Thromb Haemost
. 2019 Dec;
120(1):107-120.
PMID: 31858520
Hemolytic uremic syndrome (HUS), the leading cause of acute renal failure in children (< 3 years), is mainly related to Shiga toxins (Stx)-producing (STEC) infections. STEC are confined to the...
9.
Brigotti M, Orth-Holler D, Carnicelli D, Porcellini E, Galassi E, Tazzari P, et al.
Cell Microbiol
. 2018 Dec;
21(5):e13000.
PMID: 30578712
Hemolytic uremic syndrome (eHUS) is a severe complication of human infections with Shiga toxins (Stxs)-producing Escherichia coli. A key step in the pathogenesis of eHUS is the interaction of Stxs...
10.
Brigotti M, Arfilli V, Carnicelli D, Ricci F, Tazzari P, Ardissino G, et al.
Toxins (Basel)
. 2018 Sep;
10(9).
PMID: 30231570
Shiga toxin 2a (Stx2a) is the main virulence factor produced by pathogenic strains (Stx-producing , STEC) responsible for hemorrhagic colitis and the life-threatening sequela hemolytic uremic syndrome in children. The...